Respiratory infections predominate after day 100 following B-cell maturation antigen–directed CAR T-cell therapy

Infections are an important complication after B-cell maturation antigen (BCMA)–directed chimeric antigen receptor (CAR) T-cell therapy and risks may differ between the early and late periods. We evaluated infections in 99 adults who received a first BCMA–directed CAR T-cell therapy (commercial and...

Descripción completa

Detalles Bibliográficos
Autores principales: Little, Jessica S., Tandon, Megha, Hong, Joseph Seungpyo, Nadeem, Omar, Sperling, Adam S., Raje, Noopur, Munshi, Nikhil, Frigault, Matthew, Barmettler, Sara, Hammond, Sarah P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Immunobiology and Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514400/
https://www.ncbi.nlm.nih.gov/pubmed/37486599
http://dx.doi.org/10.1182/bloodadvances.2023010524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514400/
https://www.ncbi.nlm.nih.gov/pubmed/37486599
http://dx.doi.org/10.1182/bloodadvances.2023010524

Ejemplares similares